Published in Pain Pract on March 03, 2010
Skin Matters: A Review of Topical Treatments for Chronic Pain. Part Two: Treatments and Applications. Pain Ther (2015) 0.76
Evaluation of a novel topical essential oxygen oil for the treatment of pain in acute tendinopathy and sprains. Muscles Ligaments Tendons J (2011) 0.75
Intravenous infusions in chronic pain management. Pain Physician (2013) 2.06
Current knowledge of buprenorphine and its unique pharmacological profile. Pain Pract (2010) 1.53
Capsaicin (TRPV1 Agonist) therapy for pain relief: farewell or revival? Clin J Pain (2008) 1.47
Feasibility study of rapid opioid rotation and titration. Pain Physician (2011) 1.40
Diabetes mellitus and Alzheimer's disease: shared pathology and treatment? Br J Clin Pharmacol (2011) 1.22
Consensus guideline on parenteral methadone use in pain and palliative care. Palliat Support Care (2008) 1.20
NGX-4010, a high-concentration capsaicin dermal patch for lasting relief of peripheral neuropathic pain. Curr Opin Investig Drugs (2009) 1.12
A history of the journal of chiropractic education: twenty-five years of service, 1987-2011. J Chiropr Educ (2011) 1.11
The application of drug dose equivalence in the quantitative analysis of receptor occupation and drug combinations. Pharmacol Ther (2010) 1.07
Effects of chemotherapeutic agents 5-fluorouracil and methotrexate alone and combined in a mouse model of learning and memory. Psychopharmacology (Berl) (2008) 1.04
Topiramate antagonizes NMDA- and AMPA-induced seizure-like activity in planarians. Pharmacol Biochem Behav (2009) 1.03
Challenges of treating patients with chronic pain with dysphagia (CPD): physician and patient perspectives. Curr Med Res Opin (2013) 1.02
Antinociceptive synergy, additivity, and subadditivity with combinations of oral glucosamine plus nonopioid analgesics in mice. J Pharmacol Exp Ther (2003) 1.01
Pain coping strategies play a role in the persistence of pain in post-herpetic neuralgia. Pain (2003) 1.01
The beta-lactam antibiotic ceftriaxone inhibits physical dependence and abstinence-induced withdrawal from cocaine, amphetamine, methamphetamine, and clorazepate in planarians. Eur J Pharmacol (2008) 0.97
An NMDA antagonist (LY 235959) attenuates abstinence-induced withdrawal of planarians following acute exposure to a cannabinoid agonist (WIN 55212-2). Pharmacol Biochem Behav (2007) 0.97
A review of duloxetine 60 mg once-daily dosing for the management of diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain due to chronic osteoarthritis pain and low back pain. Pain Pract (2012) 0.97
Glutamate and aspartate measurements in individual planaria by rapid capillary electrophoresis. J Pharmacol Toxicol Methods (2010) 0.95
Nicotine behavioral pharmacology: clues from planarians. Drug Alcohol Depend (2011) 0.95
First evidence that drugs of abuse produce behavioral sensitization and cross sensitization in planarians. Behav Pharmacol (2010) 0.94
Transversus abdominis block: clinical uses, side effects, and future perspectives. Pain Pract (2013) 0.94
Identification of an additional supraspinal component to the analgesic mechanism of action of buprenorphine. Br J Pharmacol (2009) 0.92
Soy compared to casein meal replacement shakes with energy-restricted diets for obese women: randomized controlled trial. Metabolism (2007) 0.91
A nitric oxide synthase inhibitor (L-NAME) attenuates abstinence-induced withdrawal from both cocaine and a cannabinoid agonist (WIN 55212-2) in Planaria. Brain Res (2006) 0.91
New health care measures: emphasis on better management of postsurgical pain and postoperative nausea and vomiting. Hosp Pract (1995) (2014) 0.91
Continuous multimechanistic postoperative analgesia: a rationale for transitioning from intravenous acetaminophen and opioids to oral formulations. Pain Pract (2011) 0.91
Qutenza®: a capsaicin 8% patch for the management of postherpetic neuralgia. Expert Rev Neurother (2011) 0.91
Efficacy of the morphine-Adcon-L compound in the management of postoperative pain after lumbar microdiscectomy. Neurosurgery (2002) 0.89
Effects of repeated administration of chemotherapeutic agents tamoxifen, methotrexate, and 5-fluorouracil on the acquisition and retention of a learned response in mice. Psychopharmacology (Berl) (2011) 0.88
Sucrose produces withdrawal and dopamine-sensitive reinforcing effects in planarians. Physiol Behav (2013) 0.88
Perspectives on transdermal scopolamine for the treatment of postoperative nausea and vomiting. J Clin Anesth (2012) 0.86
Complex regional pain syndrome (CRPS/RSD) and neuropathic pain: role of intravenous bisphosphonates as analgesics. ScientificWorldJournal (2008) 0.86
Measurement of glutamate and aspartate in Planaria. J Pharmacol Toxicol Methods (2005) 0.85
A randomized, double-blind, placebo-controlled, two-period, crossover, pilot trial of lamotrigine in patients with central pain due to multiple sclerosis. Clin Ther (2007) 0.85
On deriving the dose-effect relation of an unknown second component: an example using buprenorphine preclinical data. Drug Alcohol Depend (2010) 0.85
Pain treatment in arthritis-related pain: beyond NSAIDs. Open Rheumatol J (2012) 0.85
U.S. board-certified pain physician practices: uniformity and census data of their locations. J Pain (2006) 0.84
Implications and limitations of appropriateness studies for chiropractic. J Chiropr Humanit (2010) 0.84
Adjuvant analgesics. Anesthesiol Clin (2007) 0.83
Prevention of postoperative pain and of epidural fibrosis after lumbar microdiscectomy: pilot study in a series of forty cases treated with epidural vaseline-sterile-oil-morphine compound. Spine (Phila Pa 1976) (2008) 0.83
Rimonabant redux and strategies to improve the future outlook of CB1 receptor neutral-antagonist/inverse-agonist therapies. Obesity (Silver Spring) (2011) 0.82
Role of pharmacogenetics in variable response to drugs: focus on opioids. Expert Opin Drug Metab Toxicol (2008) 0.82
Tramadol/paracetamol fixed-dose combination in the treatment of moderate to severe pain. J Pain Res (2012) 0.82
A reverse-phase HPLC and fluorescence detection method for measurement of 5-hydroxytryptamine (serotonin) in Planaria. J Pharmacol Toxicol Methods (2004) 0.82
Imaging intracranial plasma extravasation in a migraine patient: a case report. Pain Med (2007) 0.82
Clinically significant placebo analgesic response in a pilot trial of botulinum B in patients with hand pain and carpal tunnel syndrome. Pain Med (2006) 0.81
Withdrawal-like behavior in planarians is dependent on drug exposure duration. Neurosci Lett (2008) 0.81
Cocaine and kappa-opioid withdrawal in Planaria blocked by D-, but not L-, glucose. Brain Res (2004) 0.81
An open-label pilot trial of ibandronate for complex regional pain syndrome. Clin J Pain (2008) 0.81
A review of opioids for in-hospital pain management. Hosp Pract (1995) (2012) 0.81
Skin Matters: A Review of Topical Treatments for Chronic Pain. Part One: Skin Physiology and Delivery Systems. Pain Ther (2015) 0.81
Psoas impingement syndrome in hip osteoarthritis. Joint Bone Spine (2008) 0.80
Planarians in pharmacology: parthenolide is a specific behavioral antagonist of cocaine in the planarian Girardia tigrina. Int J Dev Biol (2012) 0.80
Differential behavioral effect of the TRPM8/TRPA1 channel agonist icilin (AG-3-5). Eur J Pharmacol (2007) 0.80
Agmatine: identification and inhibition of methamphetamine, kappa opioid, and cannabinoid withdrawal in planarians. Synapse (2008) 0.80
Extended-release formulations of tramadol in the treatment of chronic pain. Expert Opin Pharmacother (2011) 0.79
Nociceptin attenuates methamphetamine abstinence-induced withdrawal-like behavior in planarians. Neuropeptides (2008) 0.79
Tapentadol extended release for chronic pain patients. Adv Ther (2013) 0.79
Behavioral characterization of serotonergic activation in the flatworm Planaria. Behav Pharmacol (2008) 0.79
Opioid antagonists for pain. Expert Opin Investig Drugs (2013) 0.79
Management of xerostomia in older patients : a randomised controlled trial evaluating the efficacy of a new oral lubricant solution. Drugs Aging (2007) 0.79
The Oxiplex/SP gel-morphine compound after lumbar microdiscectomy in the management of postoperative pain. Report of 20 cases. Surg Neurol (2005) 0.78
Changes in aorta alpha1-adrenoceptor number and affinity during one year of streptozotocin-induced diabetes in rats. Pharmacology (2005) 0.78
Adjuvant analgesics. Med Clin North Am (2007) 0.78
In vivo comparison of harmine efficacy against psychostimulants: preferential inhibition of the cocaine response through a glutamatergic mechanism. Neurosci Lett (2012) 0.78
Drug-drug interaction between NSAIDS and low-dose aspirin: a focus on cardiovascular and GI toxicity. Expert Opin Drug Saf (2014) 0.78
Intrathecal analgesia: time to consider it for your patient? J Fam Pract (2015) 0.77
Indirect modulation of dopamine D2 receptors as potential pharmacotherapy for schizophrenia: III. Retinoids. J Clin Pharm Ther (2002) 0.77
Controlled release formulation of oxycodone in patients with moderate to severe chronic osteoarthritis: a critical review of the literature. J Pain Res (2012) 0.77
Looking beyond the administered drug: metabolites of opioid analgesics. J Fam Pract (2008) 0.77
Soy foods have low glycemic and insulin response indices in normal weight subjects. Nutr J (2006) 0.77
Isothermal titration calorimetric study of RNase-A kinetics (cCMP --> 3'-CMP) involving end-product inhibition. Pharm Res (2004) 0.77
Glutamate carboxypeptidase II (GCPII) inhibitor displays anti-glutamate and anti-cocaine effects in an invertebrate assay. Amino Acids (2011) 0.76
Acetaminophen and metabolite: lack of effect on nitric oxide synthase (constitutive or inducible). Headache (2002) 0.76
Combining opioid and adrenergic mechanisms for chronic pain. Postgrad Med (2014) 0.76
Liquid chromatography-mass spectrometric analysis of buprenorphine and its N-dealkylated metabolite norbuprenorphine in rat brain tissue and plasma. J Pharmacol Toxicol Methods (2005) 0.76
10 most commonly asked questions about the use of opioids for chronic pain. Neurologist (2004) 0.76
Skin Matters: A Review of Topical Treatments for Chronic Pain. Part Two: Treatments and Applications. Pain Ther (2015) 0.76
Non-analgesic effects of opioids: factors relevant to opioid abuse and abuse- deterrent formulations. Curr Pharm Des (2012) 0.76
Pain and obesity in the older adult. Curr Pharm Des (2014) 0.76
An open-label pharmacokinetic study of oxymorphone extended release in the presence of naltrexone in the older adult. J Opioid Manag (2012) 0.75
LiCl attenuates M(1)AChR-mediated intrathecal pilocarpine-induced reciprocal hindlimb scratching in mice. Pharmacology (2002) 0.75
Does ultrasound guidance facilitate facial botulinum injections? Headache (2013) 0.75
Endothelin antagonists in CION injury model. Pain (2006) 0.75
'Null method' determination of drug biophase concentration. Pharm Res (2011) 0.75
Risk of traumatic injury associated with chiropractic spinal manipulation in Medicare Part B beneficiaries aged 66 to 99 years. Spine (Phila Pa 1976) (2015) 0.75
5-HT(1A)-like receptor activation inhibits abstinence-induced methamphetamine withdrawal in planarians. Neurosci Lett (2010) 0.75
Evaluation of a novel topical essential oxygen oil for the treatment of pain in acute tendinopathy and sprains. Muscles Ligaments Tendons J (2011) 0.75
A patient with osteoarthritis and cardiovascular disease presenting with bilateral hip pain: a case report. Cases J (2009) 0.75
Cocaine synergism with α agonists in rat aorta: computational analysis reveals an action beyond reuptake inhibition. Drug Alcohol Depend (2012) 0.75
Chiropractic: a specialty with limitations? J Can Chiropr Assoc (2005) 0.75
The Potential Role of an Extended-Release, Abuse-Deterrent Oxycodone/Acetaminophen Fixed-Dose Combination Product for the Treatment of Acute Pain. Adv Ther (2015) 0.75
Is morphine medicine's biggest misnomer? Ann Pharmacother (2012) 0.75